In vivo and in vitro effects of copper(I)nicotinic acid complexes on lipids and lipoproteins.
el-Saadani
M
M
Inst., Med. Biochem., Univ. Graz, Austria.
Nassar
A Y
AY
Jürgens
G
G
Goher
M A
MA
el-Sayed
M
M
Esterbauer
H
H
D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D003300:Copper / Q000494:pharmacology*; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D008297:Male; D009525:Niacin / Q000494:pharmacology*; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains
D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D009525:Niacin; D003300:Copper; D002784:Cholesterol; C029892:cupric chloride